Charm Therapeutics applies AI to complex protein interactions, locking down $50M A round

The world of AI-powered drug discovery keeps expanding as the capabilities of machine learning grow. One approach that seemed unthinkable just a few years ago is simulating the complicated interplays of two interlocking molecules.

Learn more about your ad choices. Visit podcastchoices.com/adchoices

Om avsnittet

Fler avsnitt

Niobia takes the guesswork out of some of tech’s most expensive mistakes; Giraffe Bio aims its bespoke biomolecules at the looming copper shortage

Honeyjar offers AI tools to improve PR and comms at every company; plus, WindBorne wins a hefty US Air Force contract

Efferon wants to eradicate the devastating toll of pediatric sepsis; plus, Petra Power looks to modernize energy for data centers

A startup founder who served time in prison is looking to court an untapped market: ex-cons

Greenairy is building smart plant towers to clean the air in your office; plus, Robot data startup Mecka AI nabs $60M from Sequoia

Silicon Valley’s AI wunderkind launches Underdog, the most private Instinct/Muse competitor yet; plus, name Ex-Ramp engineers raise $20M for platform Melius

Hot Girl Hotline is like ‘Dear Abby’ for the AI era; plus, after Factory’s public spat with Khosla, Menlo proudly invests

Photon held a funeral for mobile apps; plus, Kevin Mandia’s new ‘agent swarm’ security startup

World’s first enhanced geothermal power plant completed in just 23 months; plus, turning idle car inventory into rental revenue

Factory CEO just accused his VC board adviser of spying for Cognition